Drug Database
Back to search

Ireland· IE-PA-EU/1/18/1315/001

Mektovi 15 mg Film-coated tablet

A binimetinib product containing binmetinib, registered in Ireland by Pierre Fabre Medicament.

ATC L01XE41

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedMektovi 15 mg Film-coated tabletATCL01XE41REGISTER NO.IE-PA-EU/1/18/1315/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about binmetinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

HPRA (Ireland)
Active substance
BINMETINIB
Manufacturer
Pierre Fabre Medicament
Country
Ireland (IE)
ATC code
L01XE41
ATC class
Binimetinib
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/18/1315/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

211 interactions on record for binimetinib.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check binimetinib against other medicinesHow interaction checks work

Binimetinib · interactions on record

211 records

  • 31 severe
  • 180 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • TipranavirJ05AE09severe
  • DasatinibL01EA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d768bcaa-cfd6-4f4e-af40-75f7986ab7a2
GET /v1/drugs/d768bcaa-cfd6-4f4e-af40-75f7986ab7a2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01XE41"
  ],
  "strength": null,
  "pa_number": "EU/1/18/1315/001",
  "substances": [
    "BINMETINIB"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "20/09/2018",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about binimetinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console